Laserfiche WebLink
or overdose fatality), and training ofhealth care personnel to identit/ and address such <br />trauma. <br />7. Support detoxification (detox) and withdrawal management services for persons with <br />OUD and any co-occurring SUD/IVIH conditions, co-usage, and/or co-addiction, <br />including medical detox, referral to treatment, or connections to other services or <br />supports. <br />8. Support training on MAT for health care providers, students, or other supporting <br />professionals, such as peer recovery coaches or recovery ouffeach specialists, <br />including telementoring to assist community-based providers in rural or underserved <br />areas. <br />9. Support workforce development for addiction professionals who work with persons <br />with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction. <br />10. Provide fellowships for addiction medicine specialists for direct patient care, <br />instructors, and clinical research for treatments. <br />11. Provide funding and training for clinicians to obtain a waiver under the federal Drug <br />Addiction Treatment Act of 2000 (DATA 2000) to prescribe MAT for OUD, and <br />provide technical assistance and professional support to clinicians who have obtained <br />a DATA 2000 waiver. <br />12. Support the dissemination of web-based training curricul4 such as the American <br />Academy of Addiction Psychiatry's Provider Clinical Support Service-Opioids web- <br />based training curriculum and motivational interviewing. <br />13. Support the development and dissemination of new curricula, such as the American <br />Academy of Addiction Psychiatry's Provider Clinical Support Service for <br />Medication-Assisted Treatment. <br />B. SUPPORTPEOPLE IN TREATMENT AND RECOVERY <br />Support people in treatment for and recovery from OUD and any co-occurring SUD/IVIH <br />conditions, co-usage, and/or co-addiction through evidence-based, evidence-informed, or <br />promising programs or strategies that may include, but are not limited to, the following: <br />1. Provide the full continuum of care of recovery services for OUD and any co-occurring <br />SUD/MH conditions, co-usage, and/or co-addiction, including supportive housing, <br />residential treatment, medical detox services, peer support services and counseling, <br />community navigators, case management, and connections to community-based <br />services. <br />2. Provide counseling, peer-support, recovery case management and residential <br />treatment with access to medications for those who need it to persons with OUD and <br />any co-occulring SUD/IMH conditions, co-usage, and/or co-addiction. <br />2 <br />H-l6